Dr. Nathaniel S. Gamsky, MD

Dr. Gamsky practices at Santa Barbara Surgery Center LP in Santa Barbara, California.

Dr. Gamsky's NPI, 1164955043, was assigned on April 6, 2017. Dr. Gamsky graduated from George Washington University School of Medicine and Health Sciences in 2017. Dr. Gamsky holds California license A162343.

Dr. Gamsky's primary practice is Santa Barbara Surgery Center LP, at 3045 De Vina St, Santa Barbara, CA 93105 in Santa Barbara County. The practice phone is (805) 569-3226.

Dr. Gamsky's primary practice is Santa Barbara Surgery Center LP in Santa Barbara, California. Dr. Gamsky is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Gamsky to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gamsky practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Gamsky's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Gamsky is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Gamsky is licensed in California.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Gamsky treats.

CMS data shows 2,342 Medicare services from Dr. Gamsky across 24 procedure codes in 2024, for 390 Medicare patients. Medicare paid $174,334 for them.

CMS counts 390 Medicare patients who saw Dr. Gamsky in 2024. The largest group is 75 to 84, with 179 patients. 75% of them have arthritis, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gamsky's median patient age at 72, with 60% women.

In 2024, Dr. Gamsky wrote 499 Medicare Part D claims for 144 patients. 96% of them were for generic drugs. CMS names the drug for 390 of them, across 9 drugs with 11 or more claims each, at $17,801 in total drug cost. In 2023, CMS named 51 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gamsky for performance year 2024, reported through an alternative payment model (APM). Dr. Gamsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gamsky as offering telehealth.

Dmand AI links 2 papers to Dr. Gamsky, published from 2016 to 2018. The most frequent topics are Length of Stay. Dr. Gamsky's most frequent co-authors are Babak Sarani, MD, Heather May Hancock, MD and Ivy Nicole Haskins, MD.

CMS Open Payments shows 60 general payments to Dr. Gamsky from 15 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 82% of the total. MML US, Inc. paid the most, $743.

Dr. Gamsky graduated from George Washington University School of Medicine and Health Sciences in 2017.

Dr. Gamsky is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.